Intervention Group for Birth Control

N/A

Waitlist Available

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at initial encounter and at follow up at 3, 6, and 12 months.

Awards & highlights

No Placebo-Only Group

Summary

This trial will assess the feasibility of initiating hormonal contraception in the pediatric emergency department.

Eligible Conditions

Birth Control
Contraceptive Behavior

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3,6, and 12 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3,6, and 12 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3,6, and 12 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Initiation of contraception in the ED using the electronic application

Secondary study objectives

Contraceptive continuation

Delivery process related outcomes #1

Delivery process related outcomes #2

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention groupExperimental Treatment1 Intervention

Using an electronic application, participants answer survey questions about their sexual history, medical history, and contraceptive preferences. They will watch a video that overviews the types of hormonal contraception. Then, based on survey answers, they will be able to watch more in-depth educational videos on methods that they qualify for. Participants will only be offered methods that are considered low risk and without any contraindication based upon responses to survey screening. This may include, contraceptive implant, medroxyprogesterone acetate injection, microgestin pills, xulane patch, or intravaginal ring. Participants will then be given the opportunity to initiate contraception in the ED. All participants will be referred for follow up outpatient health services. Subjects who have medical contraindications to certain contraceptive medications will be given a standardized handout that explains why they were not eligible for the medication(s) while in the ED.

Group II: Control GroupExperimental Treatment1 Intervention

Using an electronic application, participants answer survey questions about their background, sexual history, medical history, and contraceptive preferences. They will watch a video that overviews the types of hormonal contraception with brief pros and cons of each method. Then, based on participants medical history and contraceptive preferences they will be able to watch more in-depth counseling and educational videos on contraceptive methods that they qualify for. After these videos they will be given information on where they will be able to follow up to receive these contraceptive methods if they wish to start a method. Subjects who have medical contraindications to certain hormonal contraceptive medications will be given a standardized handout that explains why they were not eligible for the medication(s), should this come up in future discussions with their providers.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intervention Group

2020

Completed Phase 2

~7240

Do I qualify?Apply below to find out